先端医療技術開発部
研究業績
  1. Shiota T, Nagata R, Kikuchi S, Nanaura H, Matsubayashi M, Nakanishi M, Kobashigawa S, Isozumi N, Kiriyama T, Nagayama K, Sugie K, Yamashiro Y, Mori E. C9orf72-Derived Proline:Arginine Poly-Dipeptides Modulate Cytoskeleton and Mechanical Stress Response. Frontiers in Cell and Developmental Biology. 10, 750829, 2022.
  2. Hirata T, Kobayashi A, Furuse T, Yamada I, Tamura M, Tomita H, Tokoro Y, Ninomiya A, Fujihara Y, Ikawa M, Maeda Y, Murakami Y, Kizuka Y, Kinoshita T. Loss of the N-acetylgalactosamine side chain of the GPI-anchor impairs bone formation and brain functions and accelerates the prion disease pathology. The Journal of Biological Chemistry. 298, 101720, 2022.
  3. Sakurai N, Fujihara Y, Kobayashi K, Ikawa M. CRISPR/Cas9-mediated disruption of lipocalins, Ly6g5b, and Ly6g5c causes male subfertility in mice. Andrology. Epub, 2022.
  4. Hirohata T, Kitano T, Saeki C, Baba K, Yoshida F, Kurihara T, Harada K, Saito S, Mochizuki H, Shimodozono M. Quantitative behavioral evaluation of a non-human primate stroke model using a new monitoring system. Frontiers in Neuroscience. 16, 964928, 2022.
  5. Sawada K, Yoshiki A, Saito S. Editorial: Brain abnormalities due to genetic alterations or developmental exposure to environmental factors. Frontiers in Neuroscience. 16, 944861, 2022.
  6. Futani Y, Hamano M, Matsumoto R, Hashimoto S, Nishimura R, Ueda M, Arihara N, Fujii H, Ono M, Miyoshi E, Saito S, Kamada Y. Shear-Wave Elastography Using Commercially Available Ultrasound in a Mouse Model of Chronic Liver Disease. Gastrointestinal Disorders. 4, 153-164, 2022.
  7. Morimoto-Ishikawa D, Hyodo T, Takenaka M, Matsukubo Y, Numoto I, Itoh M, Ohmi M, Kamata K, Ueda Y, Wakana M, Kudo M, Saito S, Ishii K. Comparison between gradient and spin-echo (GRASE) and compressed sensing sequences for single breath-hold three-dimensional magnetic resonance cholangiopancreatography in patients with T1 hyperintense bile. European Journal of Radiology. 150, 110279, 2022.
  8. Kanno K, Koseki M, Chang J, Saga A, Inui H, Okada T, Tanaka K, Asaji M, Zhu Y, Ide S, Saito S, Higo T, Okuzaki D, Ohama T, Nishida K, Kamada Y, Ono M, Saibara T, Yamashita S, Sakata Y. Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Scientific Reports. 12, 2996, 2022.